EP 0914125 A4 20000405 - HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS
Title (en)
HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS
Title (de)
HIV-Proteaseinhibitoren, nützlich in der AIDS-Behandlung.
Title (fr)
INHIBITEURS DE LA PROTEASE DU VIH UTILISES DANS LE TRAITEMENT DU SIDA
Publication
Application
Priority
- GB 9613487 A 19960627
- US 9707131 W 19970429
- US 1669596 P 19960502
Abstract (en)
[origin: WO9740833A1] Compounds such as formula (A) or pharmaceutically acceptable salts thereof are HIV protease inhibitors. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/445 (2006.01); A61P 31/00 (2006.01); A61P 31/18 (2006.01); C07D 221/22 (2006.01); C07D 405/10 (2006.01); C07D 417/06 (2006.01)
CPC (source: EP)
A61P 31/00 (2017.12); A61P 31/18 (2017.12); C07D 221/22 (2013.01); C07D 405/10 (2013.01); C07D 417/06 (2013.01)
Citation (search report)
- [A] RANE D F: "RECENT ADVANCES IN ANTI-HIV AGENTS", EXPERT OPINION ON THERAPEUTIC PATENTS,GB,ASHLEY PUBLICATIONS, vol. 5, no. 9, 1995, pages 913 - 921, XP000654985, ISSN: 1354-3776
- See references of WO 9740833A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9740833 A1 19971106; AU 2747397 A 19971119; AU 712120 B2 19991028; CA 2252915 A1 19971106; EP 0914125 A1 19990512; EP 0914125 A4 20000405; JP 2000509392 A 20000725
DOCDB simple family (application)
US 9707131 W 19970429; AU 2747397 A 19970429; CA 2252915 A 19970429; EP 97921437 A 19970429; JP 53913597 A 19970429